Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-007607.pdf
0001558370-18-007607.rtf
0001558370-18-007607.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-007567.pdf
0001558370-18-007567.rtf
0001558370-18-007567.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-007557.pdf
0001558370-18-007557.rtf
0001558370-18-007557.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-011550.pdf
0001179110-18-011550.rtf
0001179110-18-011550.xls
CT ORDER

CT ORDER

 View HTML
9999999997-18-007614.pdf
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-010389.pdf
0001179110-18-010389.rtf
0001179110-18-010389.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-006031.pdf
0001558370-18-006031.rtf
0001558370-18-006031.xls
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-18-006090.pdf
0001558370-18-006090.rtf
0001558370-18-006090.xls
EX-101.INS - EX-101.INS
10-K/A

Amendment to a previously filed 10-K

 View HTML
0001558370-18-006096.pdf
0001558370-18-006096.rtf
0001558370-18-006096.xls
10-Q/A

Amendment to a previously filed 10-Q

 View HTML
0001558370-18-006098.pdf
0001558370-18-006098.rtf
0001558370-18-006098.xls